Martal Group:B2B Lead Generation and Sales Blog
B2B Decision Makers: Who They Are, How They Decide, and How to Find Them
Your pipeline does not stall because your product is wrong. It stalls because the person who liked your demo was never the person who could approve it, and by the time you learn that, three other stakeholders have already formed opinions you were not part of. That gap is the single most expensive problem in […]
-
Technology Lead Generation Companies: A 2026 Buyer’s Guide
Introduction If you sell software, IT services, or any complex B2B technology product, picking a lead generation partner is a high-stakes bet: the wrong one burns your prospect list, wastes a quarter, and quietly erodes your domain reputation. This guide compares the technology lead generation companies that B2B tech, SaaS, and IT teams shortlist most, […]
-
Technology Lead Generation Strategies: A Data-Driven Playbook
Technology companies sell into one of the most crowded, fastest-moving markets there is, and the buyers on the other side now run most of their evaluation before a vendor ever hears from them. Having run outbound for more than 2,000 B2B brands over 16+ years, and ranked #1 in Lead Generation on Clutch, Martal has […]
-
SDR Healthcare in 2026: Ultimate Guide to Sales Development
Introduction Healthcare B2B selling is slower, more regulated, and more crowded than almost any other market — and the Sales Development Representative (SDR) is the role that decides whether a pipeline fills or stalls. Having run outbound for 2,000+ B2B brands over 16+ years, and ranked #1 in Lead Generation on Clutch, Martal has watched […]
-
Healthcare Sales Outsourcing: How It Works, What It Costs, and When to Use It
Introduction Most healthcare companies do not struggle because their product is weak. They struggle because qualified meetings with hospital, clinic, and health-system buyers are slow, expensive, and hard to generate at a predictable rate. That is the gap healthcare sales outsourcing fills, and it is why the question keeps landing on the desks of CROs, […]
-
Healthcare Sales in 2026: Engaging Hard-to-Reach Decision-Makers & When to Outsource for B2B Success
Introduction Healthcare sales in 2026 isn’t for the faint of heart. If your team is struggling to get a response from busy hospital executives or physicians, you’re not alone: healthcare decision-makers are harder to reach than ever, buying cycles are longer, and a single deal can involve nearly a dozen stakeholders. Having run outbound for […]
-
Healthcare Marketing Agencies: How to Choose the Right Partner in 2026
Introduction Picking a healthcare marketing agency is less about who has the slickest pitch and more about who fits your buyer, your compliance reality, and the metric you actually need to move. The fastest way to waste a year is to hire a patient-acquisition shop when you sell software to hospitals, or a generalist when […]
-
Healthcare Marketing: A Data-Driven Strategy Guide for 2026
Introduction Healthcare is one of the hardest markets to sell into, and one of the most valuable to get right. For more than 16 years, Martal Group has run outbound for 2,000+ B2B brands across 50+ verticals, healthcare among them, which means we have watched what actually moves a hospital or clinic from a cold […]
-
Healthcare Lead Generation Companies in the US: A 2026 Buyer’s Guide
Introduction Selling into US healthcare is one of the hardest jobs in B2B. The buyer is rarely one person, the cycle is long, and one compliance misstep can end a deal before a demo. After more than 16 years of running B2B outbound, Martal Group sees the same pattern across medtech, health IT, and medical […]
-
Healthcare Lead Generation Strategies: How to Build Predictable B2B Pipeline in 2026
Introduction Selling into healthcare is the hardest pipeline problem in B2B, and generic tactics with the word “healthcare” pasted on top do not solve it. Martal Group has run outbound for 2,000+ B2B brands across 50+ verticals over 16+ years, healthcare among them, and the pattern is consistent: the vendors who win treat compliance, committees, […]